Fulcrum Therapeutics's Earnings Outlook

Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Wednesday, 2024-11-13. Here's what investors need to know before the announcement.

Analysts estimate that Fulcrum Therapeutics will report an earnings per share (EPS) of $-0.41.

Investors in Fulcrum Therapeutics are eagerly ...